Dyspnoea
6
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Sports Shoes and the Six-Minute Walk Test in COPD
Acute Heart Failure in Elderly Patients Admitted to the Emergency Department with Acute Dyspnea: a Multimarker Approach Prognostic Study
Treatment of Respiratory Tract Infection and/or Acute Bronchitis With Ectoin Inhalation Solution
Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis
Sonography in an Unselected Population of Acute Admitted Patients With Respiratory Symptoms
B-type NAtriuretic Peptide In Critically Ill : A Multicentric Diagnostic Study (B-rAPID)